GLP-1 V2
US$ 20.65
fda removes semaglutide shortage list 2025 GLP-1 = Over Novo Nordisk's semaglutide shortage officially
Description
Why a 6-Day Half-Life Enables Once-Weekly Dosing With a half-life of 6 days, a meaningful fraction of each dose is still circulating when the next injection is due
GLP-1 medications are generally well tolerated
dose reduction was permitted, and 2.4 mg was the lowest maintenance dose allowed
Clinicians make independent determinations based on individual eligibility
n = 48 per group
